Conformal radiotherapy for Non-Small Cell Lung Cancer (NSCLC) to the dose of 70-74 Gy with or without elective nodal irradiation (ENI). Results and patterns of failures

Nowotwory

Volumn 54, Issue 4, 2004, Pages 342-346

  Kȩpka, Lucyna ^a   Fijuth, Jacek ^a   Bujko, Krzysztof ^a   Zawadzka, Anna ^a   Blatkiewicz, Dorota ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Conformal radiotherapy; Dose escalation; Elective nodal irradiation; Non small cell lung cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED RADIOTHERAPY; DOSE RESPONSE; DOSIMETRY; ELECTIVE NODAL IRRADIATION; ESOPHAGUS DISEASE; EVALUATION; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; RADIATION PNEUMONIA; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT PLANNING;

EID: 7644239835     PISSN: 0029540X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Arriagada R, Le Chevalier T, Quoix E et al. ASTRO plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. Int J Radiat Oncol Biol Phys 1991; 20: 1183-90.
2. Perez CA, Stanley K, Grundy G. et al. Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung: Report by the RTOG. Cancer 1982; 50: 1091-99.
3. Cox JD, Azarnia N, Byhardt RW et al. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: Possible survival benefit with 69.6 Gy in favorable patients with RTOG stage III NSCLC: report of RTOG 83-11. J Clin Oncol 1990; 8: 1543-55.
4. Martel MK, Strawderman M, Hazuka MB et al. Volume and dose parameters for survival of non-small cell lung cancer patients. Radiother Oncol 1997; 44: 23-9.
5. Armstrong J, Raben A, Zelefsky M et al. Promising survival with three dimensional conformal radiation therapy for non-small cell lung cancer. Radiother Oncol 1997; 44: 17-20.
6. Derycke S, Van Duyse B, De Gersem W et al. Non-coplanar beam intensity modulation allows large dose escalation in stage III lung cancer. Radiother Oncol 1997; 45: 253-61.
7. Hayman JA, Martel MK, Ten Haken RK et al. Dose escalation in non-small cell lung cancer (NSCLC) using conformal 3-dimensional radiation therapy (3-DCRT): update of a phase I trial. Proc ASCO 1999; 18: 459a (Abstract).
8. Rosenzweig K, Yorke E, Jackson A et al. Results of a Phase I dose escalation trial in inoperable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2003; 57 (2 suppl.): 417-8.
9. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organisation for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341-46.
10. Theuws JCM, Kwa SLS, Wagenaar AC et al. Prediction of overall pulmonary function loss in relation to the 3-D dose distribution for patients with breast cancer and malignant lymphoma. Radiother Oncol 1998; 49: 233-43.
11. Graham MV, Purdy JA, Emami B et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1999; 45: 323-29.
12. Fowler JF, Chappel R. Non-small cell lung tumors repopulate rapidly during radiation therapy. Int J Radiat Oncol Biol Phys 2000; 46: 516-17.
13. Mehta M, Scrimger R, Mackie R et al. A new approach to dose escalation in non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2001; 49: 23-33.
14. Belderbos JSA, De Jaeger K, Heernsbergen WD et al. First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy. Radiother Oncol 2003; 66: 119-26.
15. Komaki R, Arzu I, Allen P et al. Radiation therapy for clinical stage I non-small cell lung cancer. Lung Cancer 2000; 29 (suppl.2): 153-4.
16. Sibley GS, Jamieson TA, Marks LM et al. Radiotherapy alone for medically inoperable stage I non-small cell lung cancer: the Duke experience. Int J Radiat Oncol Biol Phys 1998 40: 149-54.
17. Cheung PC, Yeung LT, Basrur V et al. Accelerated hypofractionation for early stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2002; 54: 1014-23.
18. Krol AD, Aussems P, Noordijk EM et al. Local irradiation alone for peripheral stage I lung cancer - could we omit the elective regional nodal irradiation? Int J Radiat Oncol Biol Phys 1996; 34: 297-302.
19. Wiliams TE, Thomas CRJ, Turrisi AT. Counterpoint: Better irradiation treatment of non-small cell lung cancer using new techniques without elective nodal irradiation. Semin Oncol 2000; 10: 308-14.